![Among the patients with stages II-IV colorectal cancer, disease free... | Download Scientific Diagram Among the patients with stages II-IV colorectal cancer, disease free... | Download Scientific Diagram](https://www.researchgate.net/profile/Hoguen-Kim/publication/51788052/figure/fig1/AS:646634685870080@1531181131021/Among-the-patients-with-stages-II-IV-colorectal-cancer-disease-free-survival-of-all.png)
Among the patients with stages II-IV colorectal cancer, disease free... | Download Scientific Diagram
![ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making - Annals of Oncology ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/82048ebc-28d3-4651-87d3-6759a8af3274/gr1.jpg)
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making - Annals of Oncology
![Clinical Outcomes in Patients With Colon Cancer With Microsatellite Instability of Sporadic or Familial Origin Treated With Adjuvant FOLFOX With or Without Cetuximab: A Pooled Analysis of the PETACC8 and N0147 Trials Clinical Outcomes in Patients With Colon Cancer With Microsatellite Instability of Sporadic or Familial Origin Treated With Adjuvant FOLFOX With or Without Cetuximab: A Pooled Analysis of the PETACC8 and N0147 Trials](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/po/2020/po.2020.4/po.19.00237/20201007/images/large/po.19.00237ta2.jpeg)
Clinical Outcomes in Patients With Colon Cancer With Microsatellite Instability of Sporadic or Familial Origin Treated With Adjuvant FOLFOX With or Without Cetuximab: A Pooled Analysis of the PETACC8 and N0147 Trials
![Distribution of microsatellite instability (MSI) status across cancer... | Download Scientific Diagram Distribution of microsatellite instability (MSI) status across cancer... | Download Scientific Diagram](https://www.researchgate.net/profile/Joseph-Vijai/publication/328620808/figure/fig1/AS:694098059087873@1542497281334/Distribution-of-microsatellite-instability-MSI-status-across-cancer-types-Tumor-types_Q640.jpg)
Distribution of microsatellite instability (MSI) status across cancer... | Download Scientific Diagram
![Consensus molecular subgroups (CMS) of colorectal cancer (CRC) and first-line efficacy of FOLFIRI plus cetuximab or bevacizumab in the FIRE3 (AIO KRK-0306) trial - Annals of Oncology Consensus molecular subgroups (CMS) of colorectal cancer (CRC) and first-line efficacy of FOLFIRI plus cetuximab or bevacizumab in the FIRE3 (AIO KRK-0306) trial - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/4b26ce91-3a5a-4ffc-888e-928efd9db3eb/gr1.jpg)
Consensus molecular subgroups (CMS) of colorectal cancer (CRC) and first-line efficacy of FOLFIRI plus cetuximab or bevacizumab in the FIRE3 (AIO KRK-0306) trial - Annals of Oncology
![Prognosis of stage II and III colon cancer treated with adjuvant 5-fluorouracil or FOLFIRI in relation to microsatellite status: results of the PETACC-3 trial† - Annals of Oncology Prognosis of stage II and III colon cancer treated with adjuvant 5-fluorouracil or FOLFIRI in relation to microsatellite status: results of the PETACC-3 trial† - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/d0e361f9-1051-4140-b654-ee73f180ea4c/gr1.jpg)
Prognosis of stage II and III colon cancer treated with adjuvant 5-fluorouracil or FOLFIRI in relation to microsatellite status: results of the PETACC-3 trial† - Annals of Oncology
![Clinical Performance of the Idylla MSI Test for a Rapid Assessment of the DNA Microsatellite Status in Human Colorectal Cancer - The Journal of Molecular Diagnostics Clinical Performance of the Idylla MSI Test for a Rapid Assessment of the DNA Microsatellite Status in Human Colorectal Cancer - The Journal of Molecular Diagnostics](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/d89bff1e-632f-4a0f-bbd4-1ad46649a7f2/gr1.jpg)
Clinical Performance of the Idylla MSI Test for a Rapid Assessment of the DNA Microsatellite Status in Human Colorectal Cancer - The Journal of Molecular Diagnostics
![International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study - The Lancet International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2119314641/2092060305/gr1.jpg)
International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study - The Lancet
![Comparison of microsatellite instability detection by immunohistochemistry and molecular techniques in colorectal and endometrial cancer | Scientific Reports Comparison of microsatellite instability detection by immunohistochemistry and molecular techniques in colorectal and endometrial cancer | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-021-91974-x/MediaObjects/41598_2021_91974_Fig1_HTML.png)
Comparison of microsatellite instability detection by immunohistochemistry and molecular techniques in colorectal and endometrial cancer | Scientific Reports
![Frontline pembrolizumab delays disease progression of colorectal cancer patients with a high microsatellite instability - BJMO Frontline pembrolizumab delays disease progression of colorectal cancer patients with a high microsatellite instability - BJMO](https://www.bjmo.be/app/uploads/2021/03/GettyImages-1259977837-1-600x400.jpg)
Frontline pembrolizumab delays disease progression of colorectal cancer patients with a high microsatellite instability - BJMO
![Frontline pembrolizumab delays disease progression of colorectal cancer patients with a high microsatellite instability - BJMO Frontline pembrolizumab delays disease progression of colorectal cancer patients with a high microsatellite instability - BJMO](https://www.bjmo.be/app/uploads/2020/04/GettyImages-840227196.jpg)
Frontline pembrolizumab delays disease progression of colorectal cancer patients with a high microsatellite instability - BJMO
![PDF) Is Adjuvant Chemotherapy Efficient in Colon Cancer with High Microsatellite Instability? A Look Towards the Future PDF) Is Adjuvant Chemotherapy Efficient in Colon Cancer with High Microsatellite Instability? A Look Towards the Future](https://i1.rgstatic.net/publication/330606055_Is_Adjuvant_Chemotherapy_Efficient_in_Colon_Cancer_with_High_Microsatellite_Instability_A_Look_Towards_the_Future/links/5e4088d0458515072d8dcfb4/largepreview.png)
PDF) Is Adjuvant Chemotherapy Efficient in Colon Cancer with High Microsatellite Instability? A Look Towards the Future
![The differential impact of microsatellite instability as a marker of prognosis and tumour response between colon cancer and rectal cancer - ScienceDirect The differential impact of microsatellite instability as a marker of prognosis and tumour response between colon cancer and rectal cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0959804911007921-gr1.jpg)
The differential impact of microsatellite instability as a marker of prognosis and tumour response between colon cancer and rectal cancer - ScienceDirect
![Evaluation of 3 molecular-based assays for microsatellite instability detection in formalin-fixed tissues of patients with endometrial and colorectal cancers | Scientific Reports Evaluation of 3 molecular-based assays for microsatellite instability detection in formalin-fixed tissues of patients with endometrial and colorectal cancers | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-020-73421-5/MediaObjects/41598_2020_73421_Fig1_HTML.png)
Evaluation of 3 molecular-based assays for microsatellite instability detection in formalin-fixed tissues of patients with endometrial and colorectal cancers | Scientific Reports
![PDF) ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making PDF) ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making](https://www.researchgate.net/profile/Alexander-Stein-4/publication/231211958/figure/fig4/AS:300553415479299@1448668926578/Treatment-algorithm-for-early-colon-cancer_Q320.jpg)
PDF) ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making
![Pembrolizumab in Microsatellite-Unstable Colorectal Cancer | NEJM Resident 360 <meta property="twitter:image" content="https://resident360files.nejm.org/image/upload/c_fit,f_auto,h_120,w_120/v1538599218/u8buf4o8mgdxgmfcczjk.png" /> <meta property="og ... Pembrolizumab in Microsatellite-Unstable Colorectal Cancer | NEJM Resident 360 <meta property="twitter:image" content="https://resident360files.nejm.org/image/upload/c_fit,f_auto,h_120,w_120/v1538599218/u8buf4o8mgdxgmfcczjk.png" /> <meta property="og ...](https://files.medstro.com/image/authenticated/s--gynGe3v0--/NEJMoa2017699_f1.jpg)
Pembrolizumab in Microsatellite-Unstable Colorectal Cancer | NEJM Resident 360 <meta property="twitter:image" content="https://resident360files.nejm.org/image/upload/c_fit,f_auto,h_120,w_120/v1538599218/u8buf4o8mgdxgmfcczjk.png" /> <meta property="og ...
![Personalized Care in Colorectal Cancer: Tailoring Treatment and Healthcare Delivery | Personalized Medicine in Oncology Personalized Care in Colorectal Cancer: Tailoring Treatment and Healthcare Delivery | Personalized Medicine in Oncology](https://www.personalizedmedonc.com/wp-content/uploads/2017/04/FigureCC_PMOMarch2017.png)
Personalized Care in Colorectal Cancer: Tailoring Treatment and Healthcare Delivery | Personalized Medicine in Oncology
![Prognostic variables in low and high risk stage III colon cancers treated in two adjuvant chemotherapy trials - European Journal of Cancer Prognostic variables in low and high risk stage III colon cancers treated in two adjuvant chemotherapy trials - European Journal of Cancer](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/12bc9bef-83b0-436b-85b6-31b018dc8d08/gr1.jpg)